GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GlaxoSmithKline (GSK) Receives Positive CHMP Opinion on Umbipro as Umbilical Cord Infection Treatment
April 29, 2016 8:23 AM EDTOn 28 April 2016, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion in accordance with Article 58 of Regulation (EC) No 726/20041 for the medicinal product Umbipro, intended for the prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants. This medicinal product has been developed by GlaxoSmithKline... More
